nmdp logo

Fresh or Frozen: The Impact of Cryopreservation on Transplant Outcomes

On-demand panel discussion link


The COVID-19 global pandemic led to a rapid transition of cryopreservation of hematopoietic cell products to ensure availability at the time of patient need. This session presents the results of several recently completed CIBMTR® (Center for International Blood & Marrow Transplant Research®) studies evaluating the impact of graft cryopreservation on outcomes in allogeneic hematopoietic cell transplantation.


  • Steven Devine, MD, Chief Medical Officer, NMDP
  • Mehdi Hamadani, Associate Professor of Medicine Medical College of Wisconsin, CIBMTR
  • Mary Eapen, MD, MS, Professor, Medical College of Wisconsin
  • Jack Hsu, MD, Clinical Associate Professor of Medicine, University of Florida